Efficacy of argon-helium cryosurgical ablation on primary hepatocellular carcinoma: A pilot clinical study

Chinese Journal of Cancer

Volumn 28, Issue 1, 2009, Pages 45-48

  Zhou, Lin ^a,b   Yang, Yong Ping ^b   Feng, Yong Yi ^b   Lu, Yin Ying ^b   Wang, Chun Ping ^b   Wang, Xin Zhen ^b   An, Lin Jing ^b   Zhang, Xin ^b   Wang, Fu Sheng ^b  

^a PLA Postgraduate Medical School   (China)

^b BEIJING 302 HOSPITAL   (China)

Author keywords

Complication; Cryosurgery; Efficacy; Liver neoplasm; Survival

Indexed keywords

ALPHA FETOPROTEIN; ARGON; HELIUM;

ABDOMINAL BLEEDING; ACUTE KIDNEY FAILURE; ADULT; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CAUSE OF DEATH; CLINICAL FEATURE; CONTROLLED STUDY; CRYOABLATION; FEMALE; HUMAN; HYPOTHERMIA; LIVER CELL CARCINOMA; LIVER DISEASE; LIVER FUNCTION; MAJOR CLINICAL STUDY; MALE; PLEURA EFFUSION; PRIMARY TUMOR; PROTEIN BLOOD LEVEL; SUBCUTANEOUS HEMORRHAGE; SURVIVAL RATE; SURVIVAL TIME; TUMOR VOLUME; WOUND INFECTION;

ADULT; AGED; ALPHA-FETOPROTEINS; ARGON; CARCINOMA, HEPATOCELLULAR; CRYOSURGERY; FEMALE; HELIUM; HUMANS; LIVER; LIVER NEOPLASMS; MALE; MIDDLE AGED; PILOT PROJECTS; POSTOPERATIVE COMPLICATIONS; SURVIVAL RATE;

EID: 67749142100     PISSN: 1000467X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Llovet JM, Bru C, Bruix J. Prognosis of hepatocellular carcinoma: the BCLC staging classification [J]. Semin Liver Dis, 1999,19(3):329-338.
2. Parkin DM, Bray F, Ferlay J, et al. Estimating the world cancer burden: Globocan 2000 [J]. Int J Cancer, 2001,94(2):153-156.
3. Jemal A, Murray T, Ward E, et al. Cancer Statistics [J]. CA Cancer J Clin, 2005,55(1):10-30.
4. Zhang KQ, Zhang JR, Wei HM. Therapeutic effects of cryoablation, radiorequency Ablation, and microwave coagulation against VX2 liver cancer: a comparative study in rabbits [J]. J First Military Med Univ, 2007,27(9):1431-1434. [in Chinese]
5. Wang ZM, Ren ZG, Wang TH, et al. The impact of Argon-Helium cryotherapy on metasis of rabbit liver tumor [J]. Fudan Univ J Med Sci, 2006,33(6):827-829. [in Chinese]
6. Permpongkosol S, Sulman A, Solomon SB, et al. Percutaneous computerized tomography guided renal cryoablation using local anesthesia: pain assessment [J]. J Urol, 2006,176(5):915-918.
7. Allaf ME, Varkarakis IM, Bhayani SB, et al. Pain control requirements for percutaneous ablation of renal tumors: cryoablation versus radiofrequency ablation-initial observations [J]. Radiology, 2005,237(1):366-370.
8. Sarantou T, Bilchik A, Ramming KP. Complications of hepatic cryosurgery [J]. Semin Surg Oncol, 1998,14(2):156-162.
9. Tierney J, Carlin B, Lupetin A, et al. Pleural effusion and atelectasis associated with cryosurgical ablation of hepatic metastases [J]. Proc Am Rev Resp Dis, 1993,147(1):A93.
10. Wen BJ, Hu LY, Shi ZY, et al. Influence of cryoablation on liver function in patients with stageIII/IV primary hepatic carcinoma [J]. Chin J Clin Oncol Rehabil, 2006,13(4):340-342. [in Chinese]
11. Mala T. Cryoablation of liver tumours-a review of mechanisms,techniques and clinical outcome [J]. Minimally Invasive Ther, 2006,15(1):9-17.
12. Su SH, Wang CP, Li YX, et al. Analysis of 320 HBV-related primary hepatocellular carcinoma [J]. World Chin J Digestology, 2003,11(11):1825-1827. [in Chinese]
13. Zhou XD, Tang ZY. Cryotherapy for primary liver cancer [J]. Semin Surg Oncol, 1998, 14(2):171-174.
14. Kerkar S, Carlin AM, Sohn RL, et al. Long-term follow-up and prognostic factors for cryotherapy of malignant liver tumors [J]. Surgery, 2004,136(4):770-779.
15. Dong JL, Ding HG, Zhao L, et al. Clinical Analysis of 396 fatal patients with HCC in BeiJing. [J]. J Capital Med Univ, 2007,28(4):532-535. [in Chinese]